219 related articles for article (PubMed ID: 11592086)
1. Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.
Haswell LE; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2001 Oct; 31(10):3094-100. PubMed ID: 11592086
[TBL] [Abstract][Full Text] [Related]
2. Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin.
Nierkens S; van Helden P; Bol M; Bleumink R; van Kooten P; Ramdien-Murli S; Boon L; Pieters R
J Immunol; 2002 Apr; 168(8):3747-54. PubMed ID: 11937525
[TBL] [Abstract][Full Text] [Related]
3. Enforced and prolonged CD40 ligand expression triggers autoantibody production in vivo.
Santos-Argumedo L; Alvarez-Maya I; Romero-Ramírez H; Flores-Romo L
Eur J Immunol; 2001 Dec; 31(12):3484-92. PubMed ID: 11745368
[TBL] [Abstract][Full Text] [Related]
4. The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules.
Green KA; Cook WJ; Sharpe AH; Green WR
J Virol; 2002 Dec; 76(24):13106-10. PubMed ID: 12438641
[TBL] [Abstract][Full Text] [Related]
5. CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A.
Eshima K; Choi Y; Flavell RA
Int Immunol; 2003 Jul; 15(7):817-26. PubMed ID: 12807820
[TBL] [Abstract][Full Text] [Related]
6. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.
Evans DE; Munks MW; Purkerson JM; Parker DC
J Immunol; 2000 Jan; 164(2):688-97. PubMed ID: 10623811
[TBL] [Abstract][Full Text] [Related]
7. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
9. Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis.
Lai JH; Luo SF; Ho LJ
Cells; 2019 Aug; 8(8):. PubMed ID: 31426619
[TBL] [Abstract][Full Text] [Related]
10. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
[TBL] [Abstract][Full Text] [Related]
11. CD154 (CD40 ligand).
Schönbeck U; Mach F; Libby P
Int J Biochem Cell Biol; 2000 Jul; 32(7):687-93. PubMed ID: 10856699
[TBL] [Abstract][Full Text] [Related]
12. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation.
Brams P; Black A; Padlan EA; Hariharan K; Leonard J; Chambers-Slater K; Noelle RJ; Newman R
Int Immunopharmacol; 2001 Feb; 1(2):277-94. PubMed ID: 11360929
[TBL] [Abstract][Full Text] [Related]
13. CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses.
Lee BO; Moyron-Quiroz J; Rangel-Moreno J; Kusser KL; Hartson L; Sprague F; Lund FE; Randall TD
J Immunol; 2003 Dec; 171(11):5707-17. PubMed ID: 14634078
[TBL] [Abstract][Full Text] [Related]
14. Signaling through CD40 enhances cytotoxic T lymphocyte generation by CD8+ T cells from mice bearing large tumors.
Donepudi M; Quach DD; Mokyr MB
Cancer Immunol Immunother; 1999; 48(2-3):153-64. PubMed ID: 10414470
[TBL] [Abstract][Full Text] [Related]
15. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.
Vyth-Dreese FA; Boot H; Dellemijn TA; Majoor DM; Oomen LC; Laman JD; Van Meurs M; De Weger RA; De Jong D
Immunology; 1998 Aug; 94(4):580-6. PubMed ID: 9767448
[TBL] [Abstract][Full Text] [Related]
16. Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo.
Förster E; Krenger W; Joergensen J; Hof R; Geha RS; Holländer GA
Transplantation; 1999 May; 67(9):1284-7. PubMed ID: 10342324
[TBL] [Abstract][Full Text] [Related]
17. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
Vonderheide RH; Butler MO; Liu JF; Battle TE; Hirano N; Gribben JG; Frank DA; Schultze JL; Nadler LM
Int J Oncol; 2001 Oct; 19(4):791-8. PubMed ID: 11562757
[TBL] [Abstract][Full Text] [Related]
18. Differential requirement for the CD40-CD154 costimulatory pathway during Th cell priming by CD8 alpha+ and CD8 alpha- murine dendritic cell subsets.
Yasumi T; Katamura K; Yoshioka T; Meguro TA; Nishikomori R; Heike T; Inobe M; Kon S; Uede T; Nakahata T
J Immunol; 2004 Apr; 172(8):4826-33. PubMed ID: 15067060
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin MJ; Brett J; Baum D; Matsushima A; Szabolcs M; Stern D; Chess L
J Exp Med; 1995 Dec; 182(6):1857-64. PubMed ID: 7500031
[TBL] [Abstract][Full Text] [Related]
20. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
